ADVANCED OVARIAN CARCINOMA

This study is testing a personalized vaccine made from a patient's own immune cells to see if it can prevent or delay the return of advanced ovarian, fallopian tube, or primary peritoneal cancer. The vaccine is designed to teach the immune system to recognize and attack cancer ce…

This is the first study in people to test a new oral medication called NKT3964. The main goals are to find a safe dose and see if the drug shows early signs of shrinking tumors in adults with advanced cancers that have spread and no longer respond to standard treatments. The stud…

This study compares two surgical approaches for advanced ovarian, fallopian tube, or primary peritoneal cancer. After initial chemotherapy, patients are randomly assigned to receive either minimally invasive 'keyhole' surgery or traditional open surgery, followed by more chemothe…

This early-stage trial is testing the safety of combining a wearable device that uses electric fields to disrupt cancer cells with different drug combinations. It is for adults with advanced cancers in the abdomen or chest that have spread and who have run out of standard treatme…

This study is testing whether taking probiotic supplements during chemotherapy can help improve gut and vaginal bacteria health in women with advanced or recurrent ovarian cancer. Researchers want to see if these supplements can reduce side effects, improve quality of life, and p…

This study is testing whether giving standard cancer treatments at home is better for patients than receiving them in a clinic. It aims to see if home care reduces stress, improves quality of life, and is safe for people with many types of advanced cancer. About 220 participants …

This study is testing a telehealth program called REVITALIZE to see if it can help reduce the severe fatigue that often interferes with daily life for people with advanced ovarian cancer who are taking PARP inhibitor medications. About 240 participants will be randomly assigned t…